Mechanism of Action: Dihydroorotate Dehydrogenase Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Dihydroorotate Dehydrogenase Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Accord Hlthcare | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209690-002 | Jan 7, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Breckenridge | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209583-002 | Sep 24, 2021 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sola Pharms | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209677-001 | Jun 17, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |